ID PHB_HUMAN Reviewed; 272 AA. AC P35232; B4DY47; Q4VBQ0; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1994, sequence version 1. DT 11-NOV-2015, entry version 155. DE RecName: Full=Prohibitin; GN Name=PHB; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ALA-88 AND RP HIS-105. RC TISSUE=Mammary gland; RX PubMed=1540973; RA Sato T., Saito H., Swensen J., Olifant A., Wood C., Danner D., RA Sakamoto T., Takita K., Kasumi F., Miki Y., Skolnick M., Nakamura Y.; RT "The human prohibitin gene located on chromosome 17q21 is mutated in RT sporadic breast cancer."; RL Cancer Res. 52:1643-1646(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8244394; DOI=10.1006/geno.1993.1402; RA Sato T., Sakamoto T., Takita K., Saito H., Okui K., Nakamura Y.; RT "The human prohibitin (PHB) gene family and its somatic mutations in RT human tumors."; RL Genomics 17:762-764(1993). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor RT vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16625196; DOI=10.1038/nature04689; RA Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., RA Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., RA Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., RA Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J., RA DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., RA Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N., RA Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B., RA Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J., RA Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E., RA Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J., RA Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C., RA Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D., RA Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A., RA Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.; RT "DNA sequence of human chromosome 17 and analysis of rearrangement in RT the human lineage."; RL Nature 440:1045-1049(2006). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Lung, and Muscle; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP PROTEIN SEQUENCE OF 5-11; 84-93; 106-128; 134-143; 178-186 AND RP 209-219, AND IDENTIFICATION BY MASS SPECTROMETRY. RC TISSUE=B-cell lymphoma; RA Bienvenut W.V.; RL Submitted (MAR-2005) to UniProtKB. RN [8] RP PROTEIN SEQUENCE OF 75-83; 94-117; 134-143; 158-177; 220-253 AND RP 256-272, AND IDENTIFICATION BY MASS SPECTROMETRY. RC TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex; RA Lubec G., Vishwanath V., Chen W.-Q., Sun Y.; RL Submitted (DEC-2008) to UniProtKB. RN [9] RP FUNCTION, INTERACTION WITH PHB2, DEVELOPMENTAL STAGE, AND INDUCTION. RX PubMed=11302691; DOI=10.1006/excr.2001.5166; RA Coates P.J., Nenutil R., McGregor A., Picksley S.M., Crouch D.H., RA Hall P.A., Wright E.G.; RT "Mammalian prohibitin proteins respond to mitochondrial stress and RT decrease during cellular senescence."; RL Exp. Cell Res. 265:262-273(2001). RN [10] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-202, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., RA Walther T.C., Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., RA Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [12] RP INTERACTION WITH STOML2. RX PubMed=21746876; DOI=10.1128/MCB.05393-11; RA Christie D.A., Lemke C.D., Elias I.M., Chau L.A., Kirchhof M.G., RA Li B., Ball E.H., Dunn S.D., Hatch G.M., Madrenas J.; RT "Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial RT biogenesis and function."; RL Mol. Cell. Biol. 31:3845-3856(2011). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-91 AND TYR-249, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., RA Wang L., Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human RT liver phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [14] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., RA Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). CC -!- FUNCTION: Prohibitin inhibits DNA synthesis. It has a role in CC regulating proliferation. As yet it is unclear if the protein or CC the mRNA exhibits this effect. May play a role in regulating CC mitochondrial respiration activity and in aging. CC {ECO:0000269|PubMed:11302691}. CC -!- SUBUNIT: Interacts with PHB2. Interacts with STOML2. CC {ECO:0000269|PubMed:11302691, ECO:0000269|PubMed:21746876}. CC -!- INTERACTION: CC Q496Y0:LONRF3; NbExp=2; IntAct=EBI-354213, EBI-2690768; CC Q13309-2:SKP2; NbExp=2; IntAct=EBI-354213, EBI-7791408; CC O14980:XPO1; NbExp=2; IntAct=EBI-354213, EBI-355867; CC -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P35232-1; Sequence=Displayed; CC Name=2; CC IsoId=P35232-2; Sequence=VSP_054922; CC Note=No experimental confirmation available.; CC -!- TISSUE SPECIFICITY: Widely expressed in different tissues. CC -!- DEVELOPMENTAL STAGE: Levels of expression in fibroblasts decrease CC heterogeneously during cellular aging. CC {ECO:0000269|PubMed:11302691}. CC -!- INDUCTION: Expression increases approximately 3-fold upon entry CC into G1 phase compared with other phases of the cell cycle. Also CC induced following inhibition of mitochondrial protein synthesis by CC thiamphenicol. {ECO:0000269|PubMed:11302691}. CC -!- SIMILARITY: Belongs to the prohibitin family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; S85655; AAB21614.1; -; mRNA. DR EMBL; L14272; AAO18340.1; -; Genomic_DNA. DR EMBL; BT007411; AAP36079.1; -; mRNA. DR EMBL; AK302258; BAG63609.1; -; mRNA. DR EMBL; AC091180; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC013401; AAH13401.1; -; mRNA. DR EMBL; BC095460; AAH95460.1; -; mRNA. DR CCDS; CCDS11548.1; -. [P35232-1] DR CCDS; CCDS62244.1; -. [P35232-2] DR PIR; I52690; I52690. DR RefSeq; NP_001268425.1; NM_001281496.1. [P35232-1] DR RefSeq; NP_001268426.1; NM_001281497.1. [P35232-2] DR RefSeq; NP_001268644.1; NM_001281715.1. [P35232-1] DR RefSeq; NP_002625.1; NM_002634.3. [P35232-1] DR UniGene; Hs.514303; -. DR PDB; 1LU7; Model; -; A=1-272. DR PDBsum; 1LU7; -. DR ProteinModelPortal; P35232; -. DR BioGrid; 111264; 83. DR DIP; DIP-24248N; -. DR IntAct; P35232; 63. DR MINT; MINT-1158239; -. DR STRING; 9606.ENSP00000300408; -. DR PhosphoSite; P35232; -. DR DMDM; 464371; -. DR DOSAC-COBS-2DPAGE; P35232; -. DR OGP; P35232; -. DR REPRODUCTION-2DPAGE; IPI00017334; -. DR REPRODUCTION-2DPAGE; P35232; -. DR SWISS-2DPAGE; P35232; -. DR UCD-2DPAGE; P35232; -. DR MaxQB; P35232; -. DR PaxDb; P35232; -. DR PeptideAtlas; P35232; -. DR PRIDE; P35232; -. DR DNASU; 5245; -. DR Ensembl; ENST00000300408; ENSP00000300408; ENSG00000167085. [P35232-1] DR Ensembl; ENST00000511832; ENSP00000425035; ENSG00000167085. [P35232-2] DR Ensembl; ENST00000614445; ENSP00000479488; ENSG00000167085. [P35232-1] DR Ensembl; ENST00000617874; ENSP00000484113; ENSG00000167085. [P35232-1] DR GeneID; 5245; -. DR KEGG; hsa:5245; -. DR UCSC; uc002iox.1; human. [P35232-1] DR CTD; 5245; -. DR GeneCards; PHB; -. DR HGNC; HGNC:8912; PHB. DR HPA; HPA003280; -. DR MIM; 176705; gene. DR neXtProt; NX_P35232; -. DR PharmGKB; PA33251; -. DR eggNOG; KOG3083; Eukaryota. DR eggNOG; COG0330; LUCA. DR GeneTree; ENSGT00550000074770; -. DR HOGENOM; HOG000205692; -. DR HOVERGEN; HBG004457; -. DR InParanoid; P35232; -. DR KO; K17080; -. DR OMA; YLNIGLD; -. DR OrthoDB; EOG7V4B04; -. DR PhylomeDB; P35232; -. DR TreeFam; TF300095; -. DR Reactome; R-HSA-5673000; RAF activation. DR GeneWiki; Prohibitin; -. DR GenomeRNAi; 5245; -. DR NextBio; 20266; -. DR PRO; PR:P35232; -. DR Proteomes; UP000005640; Chromosome 17. DR Bgee; P35232; -. DR CleanEx; HS_PHB; -. DR ExpressionAtlas; P35232; baseline and differential. DR Genevisible; P35232; HS. DR GO; GO:0009986; C:cell surface; IDA:UniProtKB. DR GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL. DR GO; GO:0005769; C:early endosome; IDA:UniProtKB. DR GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB. DR GO; GO:0005887; C:integral component of plasma membrane; IDA:HGNC. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB. DR GO; GO:0005739; C:mitochondrion; IDA:UniProtKB. DR GO; GO:0043209; C:myelin sheath; IEA:Ensembl. DR GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0001850; F:complement component C3a binding; IDA:UniProtKB. DR GO; GO:0001851; F:complement component C3b binding; IDA:UniProtKB. DR GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL. DR GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL. DR GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB. DR GO; GO:0031871; F:proteinase activated receptor binding; IPI:UniProtKB. DR GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IEA:Ensembl. DR GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL. DR GO; GO:0071354; P:cellular response to interleukin-6; IDA:BHF-UCL. DR GO; GO:0071897; P:DNA biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0016575; P:histone deacetylation; IDA:UniProtKB. DR GO; GO:0007005; P:mitochondrion organization; IMP:UniProtKB. DR GO; GO:0060766; P:negative regulation of androgen receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0030308; P:negative regulation of cell growth; IMP:BHF-UCL. DR GO; GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL. DR GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:UniProtKB. DR GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0042177; P:negative regulation of protein catabolic process; IMP:UniProtKB. DR GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; IDA:BHF-UCL. DR GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL. DR GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB. DR GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB. DR GO; GO:0045917; P:positive regulation of complement activation; IDA:UniProtKB. DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB. DR GO; GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB. DR GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB. DR GO; GO:0050847; P:progesterone receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0050821; P:protein stabilization; IMP:UniProtKB. DR GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB. DR GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB. DR GO; GO:0007165; P:signal transduction; TAS:UniProtKB. DR InterPro; IPR001107; Band_7. DR InterPro; IPR000163; Prohibitin. DR PANTHER; PTHR23222; PTHR23222; 1. DR Pfam; PF01145; Band_7; 1. DR PRINTS; PR00679; PROHIBITIN. DR SMART; SM00244; PHB; 1. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative splicing; Coiled coil; KW Complete proteome; Direct protein sequencing; DNA synthesis; Membrane; KW Mitochondrion; Mitochondrion inner membrane; Phosphoprotein; KW Polymorphism; Proto-oncogene; Reference proteome. FT INIT_MET 1 1 Removed. {ECO:0000244|PubMed:25944712}. FT CHAIN 2 272 Prohibitin. FT /FTId=PRO_0000213878. FT COILED 177 211 {ECO:0000255}. FT MOD_RES 2 2 N-acetylalanine. FT {ECO:0000244|PubMed:25944712}. FT MOD_RES 91 91 Phosphothreonine. FT {ECO:0000244|PubMed:24275569}. FT MOD_RES 128 128 N6-acetyllysine. FT {ECO:0000250|UniProtKB:P67778}. FT MOD_RES 186 186 N6-acetyllysine. FT {ECO:0000250|UniProtKB:P67778}. FT MOD_RES 202 202 N6-acetyllysine; alternate. FT {ECO:0000244|PubMed:19608861}. FT MOD_RES 202 202 N6-succinyllysine; alternate. FT {ECO:0000250|UniProtKB:P67778}. FT MOD_RES 249 249 Phosphotyrosine. FT {ECO:0000244|PubMed:24275569}. FT VAR_SEQ 140 256 Missing (in isoform 2). FT {ECO:0000303|PubMed:14702039}. FT /FTId=VSP_054922. FT VARIANT 88 88 V -> A (in a breast cancer sample; FT somatic mutation). FT {ECO:0000269|PubMed:1540973}. FT /FTId=VAR_006479. FT VARIANT 105 105 R -> H (in a breast cancer sample; FT somatic mutation). FT {ECO:0000269|PubMed:1540973}. FT /FTId=VAR_006480. SQ SEQUENCE 272 AA; 29804 MW; 915494273E342C76 CRC64; MAAKVFESIG KFGLALAVAG GVVNSALYNV DAGHRAVIFD RFRGVQDIVV GEGTHFLIPW VQKPIIFDCR SRPRNVPVIT GSKDLQNVNI TLRILFRPVA SQLPRIFTSI GEDYDERVLP SITTEILKSV VARFDAGELI TQRELVSRQV SDDLTERAAT FGLILDDVSL THLTFGKEFT EAVEAKQVAQ QEAERARFVV EKAEQQKKAA IISAEGDSKA AELIANSLAT AGDGLIELRK LEAAEDIAYQ LSRSRNITYL PAGQSVLLQL PQ //